ProShare Advisors LLC - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 86 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$34,539
+35.8%
14,512
+0.4%
0.00%
Q2 2023$25,438
-52.0%
14,454
+21.9%
0.00%
Q1 2022$53,000
-48.5%
11,861
-21.4%
0.00%
Q4 2021$103,000
-16.9%
15,084
-11.3%
0.00%
Q3 2021$124,000
-33.7%
17,002
-8.7%
0.00%
-100.0%
Q2 2021$187,000
+12.7%
18,630
+6.9%
0.00%0.0%
Q1 2021$166,000
+21.2%
17,434
+39.3%
0.00%0.0%
Q4 2020$137,00012,5160.00%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,043,267$2,692,0001.92%
SILVERARC CAPITAL MANAGEMENT, LLC 380,606$982,0000.30%
Pentwater Capital Management LP 4,967,227$12,815,0000.15%
Atom Investors LP 55,827$144,0000.06%
Corton Capital Inc. 14,978$39,0000.04%
Forefront Analytics, LLC 23,370$61,0000.03%
Delphia (USA) Inc. 15,799$41,0000.03%
Advisory Services Network, LLC 259,571$670,0000.02%
Laurion Capital Management LP 545,700$1,408,0000.02%
MCF Advisors LLC 59,659$154,0000.02%
View complete list of POSEIDA THERAPEUTICS INC shareholders